These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date 2004-002076-42 Safety, hemostatic and metabolic effects and contraceptive efficacy of an oral monophasic contraceptive containing 0.03 mg ethinylestradiol and 2 mg chlormadinone acetate (CG5025) used in two differen... 2006-02-09 bad-data
Reported results 2004-003035-31 Safety of the oral monophasic contraceptive GRT4248 (0.02 mg ethinylestradiol/2 mg chlormadinone acetate) in comparison to 0.02 mg ethinylestradiol/0.15 mg desogestrel given for 6 medication cycles Ra... 2016-07-21 due-trials
Reported results 2005-001404-40 Cross-over multiple dose study assessing the analgesic efficacy and safety of oral GRT9906 PR compared to active comparator and placebo in subjects with painful polyneuropathy of mixed origin 2006-08-21 due-trials
Reported results 2005-001656-21 A randomized, multi-center, double-blind, parallel-group, multiple-dose study assessing the analgesic efficacy and safety of 3 different doses of GRT0151Y compared to placebo and an active comparator ... 2006-02-17 due-trials
Reported results 2005-003360-26 A randomized, multi-centre, double blind, parallel-group study assessing the analgesic efficacy and safety of different dosages of GRT0151Y bid compared to active comparator bid and placebo bid in sub... 2006-08-11 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-005365-11 A randomised, 2-arm, parallel group study assessing efficacy and tolerability of titrated transdermal buprenorphine in patients with moderate to severe chronic non malignant pain 2006-08-03 bad-data
Reported results 2006-003132-29 Eficacia y Seguridad de un parche de lidocaína al 5% comparado con pregabalina en neuralgia post-herpética y dolor por polineuropatía diabética. 2008-01-14 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-003482-14 A One-Year, Randomized, Open-Label, Parallel-Arm, Phase III Long-Term Safety Trial, with Controlled Adjustment of Dose, of Multiple Doses of CG5503 PR and Oxycodone CR in Subjects with Chronic Pain 2008-07-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-004997-28 A randomized withdrawal, active- and placebo-controlled, double-blind, multi-center Phase III trial assessing safety and efficacy of oral CG5503 PR in subjects with moderate to severe chronic malignan... 2012-06-19 bad-data
Reported results 2006-004998-95 A randomized, double-blind, parallel-arm, placebo- and comparator-controlled trial of the efficacy and safety of multiple doses of immediate-release (IR) CG5503 for postoperative pain following abdomi... 2008-02-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-005783-67 A Randomized Double-Blind, Placebo- and Active-Control, Parallel-arm, Phase III Trial with Controlled Adjustment of Dose to Evaluate the Efficacy and Safety of CG5503 Prolonged-Release (PR) in Subject... 2008-07-18 bad-data
Reported results 2008-004794-18 A randomized Phase IIa trial evaluating the safety and efficacy of a new centrally acting analgesic in subjects with pain due to diabetic polyneuropathy 2010-05-25 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-010423-58 An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with uncontrolled severe chroni... 2010-09-10 bad-data
Reported results 2009-010425-39 An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with severe chronic pain due to... 2010-08-12 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-010427-12 An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with uncontrolled severe chroni... 2010-07-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-010428-25 An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with severe chronic nociceptive... 2011-01-21 bad-data
Reported results 2009-013291-46 Ensayo clínico de Fase III abierto, de un solo grupo y con dosificación flexible de tapentadol LP oral en pacientes con dolor tumoral crónico que hayan completado el Periodo de Mantenimiento del estud... 2014-05-29 due-trials
Reported results 2009-015397-35 A multicenter, open-label trial to assess cognitive and psychomotor performance as surrogate parameters for driving ability under stable long term treatment with tapentadol hydrochloride prolonged-rel... 2010-09-03 due-trials
Reported results 2009-015527-82 Estudio abierto de extensión para los pacientes con lumbalgia crónica severa o dolor crónico severo debido a artrosis de rodilla que han completado alguno de los ensayos clínicos previos de fase IIIb ... 2011-12-14 due-trials
Ongoing, reported early 2009-016337-10 Lidocaine 5% medicated plaster for the topical treatment of localized chronic postoperative neuropathic pain after total knee replacement or thoracotomy not-yet-due
Ongoing, reported early 2009-017470-20 An open-label extension study for patients with severe chronic low back pain or severe chronic pain due to knee osteoarthritis who have completed any of the previous phase IIIb trials with tapentadol ... not-yet-due
Reported results 2010-019998-14 Evaluación de la efectividad, seguridad y tolerabilidad de tapentadol de liberación prolongada frente a una combinación de tapentadol de liberación prolongada y pregabalina en pacientes con lumbalgia... 2012-01-17 due-trials
Reported results 2010-022556-23 A randomized 4 week Phase IIa trial evaluating the efficacy, safety, and tolerability of GRT6005, a new centrally acting analgesic in subjects with moderate to severe pain due to osteoarthritis (OA) o... 2011-12-15 due-trials
Reported results 2010-022557-42 A randomized 4-week Phase IIa trial evaluating the efficacy, safety, and tolerability of GRT6005, a new centrally acting analgesic, in subjects with pain due to diabetic polyneuropathy. 2012-01-05 due-trials
Reported results 2011-002092-42 Evaluation of the efficacy, tolerability, and safety of 7 days of treatment with GRT6010 or pregabalin in comparison to placebo in subjects with peripheral neuropathic pain. 2013-01-18 due-trials
Reported results 2012-000347-28 Efficacy and safety of lidocaine 5% medicated plaster in localized chronic post-operative neuropathic pain 2016-06-21 due-trials
Reported results 2012-001316-35 Efficacy, safety, and tolerability of oral cebranopadol versus morphine sulphate PR in subjects with chronic moderate to severe pain related to cancer. 2015-10-16 due-trials
Reported results 2012-001920-36 Efficacy, safety, and tolerability of GRT6005 in subjects with moderate to severe chronic low back pain 2014-07-10 due-trials
Reported results 2012-002943-11 Evaluation of the effectiveness, safety, and tolerability of tapentadol PR versus oxycodone/naloxone PR in non-opioid pre-treated subjects with uncontrolled severe chronic low back pain with a neuro... 2014-01-28 due-trials
Ongoing, reported early 2012-004359-35 An evaluation of the efficacy and safety of tapentadol oral solution in the treatment of post-operative acute pain requiring opioid treatment in pediatric subjects aged from birth to less than 18 year... not-yet-due
Listed as ongoing, but also has a completion date 2012-004360-22 An open label trial, enrolling subjects aged 6 years to less than 18 years suffering from pain requiring prolonged release opioid treatment, to evaluate the safety and efficacy of tapentadol PR versus... 2018-10-15 bad-data
Reported results 2012-005499-33 Relative bioavailability trial to investigate the pharmacokinetics of tapentadol following the administration of 3 prototype tapentadol 25 mg prolonged release (PR) granule formulations compared to a ... 2015-06-15 due-trials
Reported results 2013-000473-68 Efficacy, safety and tolerability of multiple doses of oral cebranopadol in subjects with moderate to severe chronic pain due to diabetic peripheral neuropathy 2015-01-28 due-trials
Reported results 2013-001877-26 An open-label, multi-site trial to describe the safety and tolerability of oral cebranopadol administered for 26 weeks in subjects with cancer-related pain who have completed treatment in the KF6005/0... 2016-05-03 due-trials
Trial is outside EEC, and reported results 2013-002016-27 Open-label evaluation of the pharmacokinetic profile, safety, and efficacy of tapentadol oral solution for the treatment of post-surgical pain in children and adolescents aged from 2 years to less tha... bad-data
Reported results Terminated 2014-000623-24 Open-label evaluation of the population pharmacokinetic profile, safety, tolerability, and efficacy of tapentadol oral solution for the treatment of post-surgical pain in children aged from birth to l... 2016-12-14 due-trials
Reported results 2014-001915-37 A randomized, double-blind trial investigating the efficacy and safety of intravenous neridronic acid in subjects with complex regional pain syndrome type I (CRPS-I) 2016-11-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2014-002259-24 Open-label evaluation of the population pharmacokinetic profile, safety, tolerability, and efficacy of intravenous tapentadol solution for injection for the treatment of post-surgical pain in children... 2018-09-27 bad-data
Listed as ongoing, but also has a completion date 2016-001164-11 Open-label safety trial of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS) 2019-01-09 bad-data
Completed, but no date 2016-002259-11 A multicenter, open-label, single-arm, Phase IIIb trial to evaluate the effectiveness, safety, tolerability, usability and health economics resource utilization of Zalviso® for management of acute mod... bad-data
Reported results 2016-002611-18 An exploratory, randomized, double-blind, double-dummy, placebo- and active-controlled Phase II trial to evaluate the efficacy and safety of a topical application of GRT7019 in subjects with chronic p... 2018-01-17 due-trials
Ongoing 2016-003833-91 Randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS) not-yet-due
Completed, reported early 2016-003940-35 Exploratory, randomized, double-blind, placebo-controlled evaluation of efficacy, tolerability, and safety of intravesical instillation of GRT6010 compared to placebo in subjects with bladder pain syn... 2018-05-02 not-yet-due
Ongoing 2017-004244-37 Placebo-controlled efficacy and safety trial of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS) not-yet-due